Ameren vs NiSource
AEE and NI side by side, both in combination electric and gas, and other utility. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AEE and NI compare
Ameren is the larger company, worth 1.4 times as much as NiSource ($31.8B against $22.1B).
On earnings, Ameren is cheaper: it trades at 20.2× trailing earnings, against 23.5× for NiSource.
NiSource grew revenue faster over the last twelve months (15.3% versus 3.8% for Ameren).
Both pay dividends: Ameren yields 2.6% and NiSource 2.0%.
NiSource scores higher on the StockData Score (6 against 3 for Ameren), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AEE | NI |
|---|---|---|
| Size and price | ||
| Market cap | $31.8B | $22.1B |
| Share price | $114.77 | $46.05 |
| Change, 1 year | 8.6% | 5.5% |
| Change, 5 years | 34.4% | 82.6% |
| Beta (5Y) | 0.36 | 0.45 |
| Employees | – | 7,738 |
| StockData Score | ||
| Total score | 3 | 6 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 0 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 20.2× (better) | 23.5× |
| P/S | 3.6× | 1.9× (better) |
| P/B | 2.3× | 2.3× (better) |
| EV/EBITDA | 14.0× | 13.3× (better) |
| PEG | 2.26 (better) | 5.02 |
| FCF yield | −4.4% (better) | −7.1% |
| Fair value | $104.36 | $41.12 |
| Margin of safety | −10.0% (better) | −12.0% |
| Growth | ||
| Revenue growth (TTM) | 3.8% | 15.3% (better) |
| Revenue growth, 5Y average | 8.7% (better) | 7.8% |
| Net income growth (TTM) | – | 4.9% |
| EPS growth (TTM) | 24.8% (better) | 3.2% |
| EPS growth, 5Y average | 8.9% | – |
| Profitability | ||
| Gross margin | – | 86.4% |
| Operating margin | 24.9% (better) | 16.6% |
| Net margin | – | 8.2% |
| FCF margin | −16.0% | −13.7% (better) |
| Return on equity | – | 10.1% |
| Return on invested capital | 5.9% (better) | 5.7% |
| Financial health | ||
| Debt / equity | 1.59 (better) | 1.91 |
| Net debt / EBITDA | 5.68 | 5.68 (better) |
| Interest coverage | 2.6× (better) | 2.4× |
| Current ratio | 0.53 (better) | 0.50 |
| Altman Z-score | 0.92 (better) | 0.87 |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% (better) | 2.0% |
| Payout ratio | – | 60.8% |
| Years of dividend growth | 12 (better) | 9 |
| Dividend growth, 5Y average | 7.3% (better) | 5.9% |
| Buyback yield | −1.8% | −0.29% (better) |
| Shareholder yield | 0.78% | 1.7% (better) |
| Ownership | ||
| Held by institutions | 88.5% | 96.4% |
| Held by insiders | 0.36% | 0.37% |
| Insider net buying, 12 months | −$8.1M | −$6.9M (better) |
| Short interest, % of float | 5.7% | 4.2% |
Go deeper
- AEE stock overview
- AEE income statement
- AEE valuation and score
- NI stock overview
- NI income statement
- NI valuation and score
Other comparisons
- AEE vs CMS
- AEE vs EVRG
- AEE vs LNT
- AEE vs WEC
- AES vs NI
- CMS vs NI
- CMS.PB vs NI
- DUK vs NI
- ED vs NI
- EXC vs NI
- NI vs PCG
- NI vs PEG
For information only, not investment advice. Check the source filings before relying on any figure.